Navigation Links
Hologic to Host Investor Presentation at RSNA 2010
Date:10/13/2010

BEDFORD, Mass., Oct. 13 /PRNewswire-FirstCall/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the Company will host a presentation for members of the investment community at the 2010 RSNA (Radiological Society of North America) trade show in Chicago, IL. RSNA is the world's largest medical meeting. For more information about RSNA, please visit http://rsna2010.rsna.org/.

Hologic's investor meeting will be held on Tuesday, November 30, 2010, at McCormick Place from 8:00 to 10:00 a.m. (Central Time) and will include a presentation by members of Hologic's management team.

Interested participants may listen to the call (listen mode only) by dialing 866-277-1182 or 617-597-5359, passcode 42874701 beginning at 7:50 a.m. (Central Time) and referencing the Hologic Investor Meeting. For those unable to participate in the live broadcast, a replay will be available two hours after the call ends through Friday, December 17, 2010 at 888-286-8010 or 617-801-6888, passcode 18488130.  

Interested parties are invited to listen to a live audio webcast of Hologic's presentation on the investor section of the company's website at www.hologic.com/investor. An archive of the presentation will be available for replay following the event.

About Hologic, Inc.Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.Contact:

Deborah GordonVice President, Investor RelationsHologic, Inc.(781) 999-7716
'/>"/>

SOURCE Hologic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hologic to Release Fourth Quarter Fiscal 2010 Operating Results on Monday, November 8, 2010
2. Hologics Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
3. Hologic to Present at the 2010 Morgan Stanley Global Healthcare Conference
4. Ethicon Endo-Surgery Announces Agreement with Hologic Inc. To Resolve Patent Disputes
5. Hologic Announces Decision in Patent Infringement Suit
6. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
7. New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity
8. Hologic to Feature Adiana(R) Permanent Contraception System at AAGL 2009
9. Hologic to Present at NASDAQ OMX 23rd Investor Program in London
10. Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results
11. Hologic to Present at Citis 2009 Sixth Annual Small/Mid Cap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
(Date:4/24/2017)... ... April 24, 2017 , ... In ... be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research into ... this type of healthcare model in the diagnosis and treatment of brain tumors. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of Gardant ... website. , Rod has been at the forefront of Gardant since it was founded ... Rod has overseen the opening of more than 40 new senior living communities. With ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for her ... good news for single women is that she put all the words in her ... 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... familiar. This makes it difficult for lab operators and management to assess these ... help them identify wasteful or unnecessary actions. , Created with the help ...
Breaking Medicine News(10 mins):